Fourth dose now recommended for cancer patients over 16 The change in ATAGI advice will affect the COVID vaccine recommendations for cancer patients aged 16 and 17 with immediate effect.
Research shows BRCA-related cancers not a ‘female-only thing’ Males who carry a fault in BRCA1 or BRCA2 genes may be at greater risk of prostate, breast, stomach and pancreatic cancers, a new study suggests.
Doctors again voice opposition to pharmacy prescribing The decision to extend a UTI pharmacy prescribing pilot program has prompted a warning from the RACGP and Urological Society of Australia.
‘Disturbing’ rise in young-onset gastrointestinal cancers Local and international experts are worried about the rising numbers of young people under 50 being diagnosed with gastrointestinal cancers.
COVID vaccination for immunocompromised cancer patients Oncologist Professor Eva Segelov details important clinical information specific to this vulnerable cohort.
Patients most at risk of missing out on non-COVID healthcare New data aims to help GPs prioritise certain patient cohorts to mitigate future risk. But with the system under pressure, is this realistic?
Further primary care software integration with NCSR A third provider has integrated with the National Cancer Screening Register to boost participation in under-screened communities.
Pandemic delays cancer diagnoses Research shows a new pandemic could be just over the horizon, and this time it’s cancer.
Can PPIs impact lung cancer treatment? New research suggests a common medication used by up to 30% of cancer patients may adversely affect immune therapy treatment.
Australia continues push to eliminate cervical cancer The Federal Government has pledged almost $6 million towards the goal of eliminating the disease by 2035.